Psyllium husk — the 200% review

What it claims

• Acts like 'natural Ozempic' — same appetite-suppressing effect as GLP-1 drugs
• Lowers cholesterol, regulates blood sugar, improves regularity
• Helps with weight loss, cravings, even nicotine and alcohol urges
• Detoxes the gut, feeds the microbiome, fixes inflammation

What the label is not telling you

• It is not Ozempic. Psyllium does raise endogenous GLP-1, PYY and GIP modestly via SCFA-driven L-cell signalling in the distal gut (Müller 2018; Cani 2019). Semaglutide raises pharmacological GLP-1 by orders of magnitude. The mechanism rhymes; the magnitude doesn't. Anyone selling psyllium as a 1:1 GLP-1 substitute is overselling. As an adjunct to a regulated baseline — or as a non-pharmacological floor for people who don't qualify for or want a GLP-1 drug — it earns its place.
• The cholesterol data is the strongest finding. Meta-analyses across 28+ RCTs (Jovanovski 2018, AJCN) show ~7 g/day psyllium lowers LDL by 6–24 mg/dL and is FDA-recognised for a coronary heart disease risk-reduction claim. This is one of the most replicated nutritional findings in cardiology.
• The glucose data is real. 10–15 g/day before meals reduces post-prandial glucose by 13–20% in type 2 diabetes (Gibb 2015, AJCN). Mechanism: viscosity-driven delayed gastric emptying + slower carbohydrate absorption + colonic SCFA feedback on insulin sensitivity. This is why pre-meal psyllium has quietly become standard practice in metabolic clinics.
• Satiety effect is genuine but modest. ~7 g before meals increases fullness ratings and reduces ad-libitum intake by 50–100 kcal/meal in controlled trials (Brum 2016). Over months this compounds; in a single afternoon it will not silence the appetite the way 2.4 mg semaglutide does.
• The 'addiction' headline is over-extended. The reel circulating in 2026 references early animal and small human work suggesting GLP-1 signalling modulates dopaminergic reward, including nicotine and alcohol salience. Endogenous GLP-1 elevation from fibre is real; whether it meaningfully shifts addictive behaviour at fibre-induced doses is not established. Treat the alcohol/nicotine claim as plausible adjunct, not therapy.
• Brand matters less than form. Generic ispaghula husk powder (NOW Foods, Lepicol, pharmacy-grade) is the same molecule as the premium versions. Metamucil adds aspartame, sucralose, artificial colour, and citric acid in most flavoured SKUs — useful for compliance, unnecessary mechanistically. Capsules deliver 0.5–1 g per cap; you need 10+ caps to match one teaspoon of powder. Powder is cheaper, cleaner, and dose-flexible.
• The water rule is non-negotiable. Psyllium expands 10–20× in liquid. Taken dry, with insufficient water, or by anyone with a swallowing or oesophageal stricture risk, it can cause genuine obstruction. The FDA has black-box-level warnings on this for a reason. Mix with ≥250 ml water, drink immediately, follow with another 250 ml.
• It will bind your meds. Psyllium reduces absorption of levothyroxine, lithium, carbamazepine, digoxin, warfarin, metformin, and most oral contraceptives if taken within 2 hours. This is a real interaction, not a theoretical one. Separate by 2–4 hours.

Effect on the nervous system

Better than the supplement category deserves. The mechanism that matters for a nervous-system audience is the gut-brain feedback loop. Psyllium ferments in the colon into short-chain fatty acids — butyrate, propionate, acetate — which (a) feed colonocytes, (b) reduce systemic inflammation, (c) trigger L-cells to release GLP-1 and PYY, and (d) signal the vagus nerve directly via free-fatty-acid receptors FFAR2/3 on enteric neurons. That last one is the under-discussed piece: the vagal afferents from the gut to the brainstem carry roughly 80% of vagal traffic. Feeding the colon properly is, in a literal autonomic sense, feeding the vagus. People running the Burnout, Wired-Tired, or GLP-1 Anchor often report — within 2–3 weeks of consistent psyllium — flatter post-meal energy curves, less reactive hunger, and a steadier baseline. None of that replaces sleep, daylight, protein, breathwork, or the actual Anchor work. But it is a high-leverage, low-cost addition to a regulated baseline.

Who it might suit

Adults — all genders — with LDL cholesterol above optimal, type 2 diabetes or pre-diabetes, post-meal glucose spikes, low-fibre Western diet (<25 g/day), constipation, IBS-C, recovery from antibiotic courses, anyone running the GLP-1 Anchor as an adjunct to semaglutide/tirzepatide for the gastroparesis and constipation side-effect window, anyone who wants the metabolic benefits of GLP-1-style signalling without (or before) pharmacotherapy. Useful in the Wired-Tired and Burnout Anchors for the SCFA-vagal feedback.

Who should skip it

Anyone with a history of oesophageal stricture, swallowing difficulty, bowel obstruction, severe gastroparesis, or active inflammatory bowel disease flare — talk to a clinician first. Anyone on levothyroxine, lithium, carbamazepine, digoxin, warfarin, oral contraceptives, or metformin without separating dosing by 2–4 hours. Anyone using it as a replacement for an actual GLP-1 prescription when one is clinically indicated. Anyone who tries to start at 15 g/day on day one — start at 3–5 g and titrate over a week, or the bloating is genuinely unpleasant.

Bottom line

Psyllium husk is one of the few supplements where the boring clinical literature is stronger than the TikTok claims. It is not Ozempic; it does not need to be. It is a 7–15 g/day soluble fibre that lowers LDL, blunts post-meal glucose, raises endogenous GLP-1/PYY modestly, feeds the colonocytes that talk to your vagus nerve, and costs less than a coffee per week. Take 5–10 g in 250+ ml water, 20–30 minutes before your largest meal, separated from medications by 2–4 hours. Pair it with the GLP-1 Anchor if you are running pharmacotherapy, or with the Burnout Anchor if you are using it as a metabolic floor. The verified version we keep on the kitchen counter — and the rest of the gut-brain stack — sits at thecodex.world.